-
News | 2023.09.19
HIV-AIDS : inspiring patients
With early and rigorous treatment, some so-called "controller" patients are able to keep their viral load low enough to not suffer from AIDS. These are inspiring cases for research, not to mention the very rare patients who have already been completely cured of HIV.
-
News | 2023.05.24
Legionellosis: the bacteria use a novel strategy to infect more efficiently
Legionellosis is a disease caused by the bacterium Legionella pneumophila. Scientists from the Institut Pasteur have described for the first time, the process used by these bacteria to modify epigenetic marks in the host cell. This mechanism enables L. pneumophila to evade the immune response and to trigger infection.
-
Événement | 2023.06.27
Life sciences meet the climate
The Human Frontier Science Program (HFSP) and its partners, including Institut Pasteur, are organizing two free events and open to the public: an International Science Summit and a Scientific Symposium.From 27-29 June 2023 in Paris, scientists representing diverse disciplines, international government officials, leaders of science funding agencies, and more, will meet at the « Fundamental...
-
News | 2023.06.05
Emerging diseases: DURABLE, a European project led by the Institut Pasteur
The European project DURABLE, led by the Institut Pasteur, has been launched in February, 2023. DURABLE means Delivering a Unified Research Alliance of Biomedical and public health Laboratories against Epidemics. It is a network whose main objective is to develop a one-stop shop for emerging disease laboratory preparedness. This 4-year large-scale project will help to build stronger, more...
-
News | 2023.06.14
DARRI at the Hellenic Pasteur Institute: Innovation and Technology Transfer Workshop
From June 26 to 29, 2023, The Hellenic Pasteur Institute, member of the Pasteur Network, is organizing a workshop on technology transfer in biological sciences and public health. Targeting young researchers from all over the world, it will offer an opportunity to immerse in the innovation ecosystem. Some members of Institut Pasteur's Technology Transfer and Industrial Partnership Department (...
-
News | 2023.06.05
HIV-AIDS: a fight for life, 40 years after the discovery of the virus
Forty years after the identification of the AIDS virus (HIV), the Institut Pasteur honored Françoise Barré-Sinoussi, co-discoverer of HIV with Prof. Luc Montagnier in 1983, both Nobel Prize winners in 2008. Through this exceptional researcher, we celebrated the commitment and fight for life of all players involved in the fight against HIV-AIDS. A short film retracing the 40 years that separate us...
-
News | 2023.06.07
New Online Certificate In Healthcare Entrepreneurship
The Institut Pasteur and ESCP Business School in Paris have developed a new online program for learners preparing to enter the demanding ecosystem of healthcare entrepreneurship. Led by professors Frédéric Jallat (ESCP) and Dominique Franco (Institut Pasteur), this high-level course, taught in English, offers the keys to achieving success in innovation. It includes contributions from...
-
News | 2023.06.08
Virtual Reality Surgical Planning: AVATAR MEDICAL receives FDA Clearance
On June 8, 2023, AVATAR MEDICAL, a spin-off of the Institut Pasteur and Institut Curie, both granted with the Carnot Label, received 510(k) clearance from the Food and Drug Administration (FDA) for its virtual reality surgical planning solution. AVATAR MEDICAL instantly converts CT scans and MRI images into patient avatars, detailed 3D and virtual reality (VR) representations of the patient's...
-
Article | 2023.06.09
Get personalized career support
If you are a Master's or PhD student, postdoctoral fellow, engineer or scientist at the Institut Pasteur, the Career Development Service for Scientists offers a personalized career support program to help you develop your career plan, in a fair and inclusive working environment for all.
-
Document de presse | 2023.06.02
Immunotherapy for blood cancer: remote destruction of tumor cells demonstrated
The aim of immunotherapy strategies is to use cells in the patient's own immune system to destroy tumor cells. CAR T cell therapy is an immunotherapy that is effective in treating blood cancer. Around 35,000 people are affected by blood cancer each year in France, with 1.24 million cases worldwide. By closely investigating some of the immune cells generated during this therapy, known as CD4 T...
